Cell Division and the Anaphase-Promoting Complex
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice
Loyola University Chicago Loyola eCommons Biology: Faculty Publications and Other Works Faculty Publications 2013 Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice Mihaela Palicev Gunter P. Wagner James P. Noonan Benedikt Hallgrimsson James M. Cheverud Loyola University Chicago, [email protected] Follow this and additional works at: https://ecommons.luc.edu/biology_facpubs Part of the Biology Commons Recommended Citation Palicev, M, GP Wagner, JP Noonan, B Hallgrimsson, and JM Cheverud. "Genomic Correlates of Relationship QTL Involved in Fore- Versus Hind Limb Divergence in Mice." Genome Biology and Evolution 5(10), 2013. This Article is brought to you for free and open access by the Faculty Publications at Loyola eCommons. It has been accepted for inclusion in Biology: Faculty Publications and Other Works by an authorized administrator of Loyola eCommons. For more information, please contact [email protected]. This work is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 License. © Palicev et al., 2013. GBE Genomic Correlates of Relationship QTL Involved in Fore- versus Hind Limb Divergence in Mice Mihaela Pavlicev1,2,*, Gu¨ nter P. Wagner3, James P. Noonan4, Benedikt Hallgrı´msson5,and James M. Cheverud6 1Konrad Lorenz Institute for Evolution and Cognition Research, Altenberg, Austria 2Department of Pediatrics, Cincinnati Children‘s Hospital Medical Center, Cincinnati, Ohio 3Yale Systems Biology Institute and Department of Ecology and Evolutionary Biology, Yale University 4Department of Genetics, Yale University School of Medicine 5Department of Cell Biology and Anatomy, The McCaig Institute for Bone and Joint Health and the Alberta Children’s Hospital Research Institute for Child and Maternal Health, University of Calgary, Calgary, Canada 6Department of Anatomy and Neurobiology, Washington University *Corresponding author: E-mail: [email protected]. -
Protein Interaction Network of Alternatively Spliced Isoforms from Brain Links Genetic Risk Factors for Autism
ARTICLE Received 24 Aug 2013 | Accepted 14 Mar 2014 | Published 11 Apr 2014 DOI: 10.1038/ncomms4650 OPEN Protein interaction network of alternatively spliced isoforms from brain links genetic risk factors for autism Roser Corominas1,*, Xinping Yang2,3,*, Guan Ning Lin1,*, Shuli Kang1,*, Yun Shen2,3, Lila Ghamsari2,3,w, Martin Broly2,3, Maria Rodriguez2,3, Stanley Tam2,3, Shelly A. Trigg2,3,w, Changyu Fan2,3, Song Yi2,3, Murat Tasan4, Irma Lemmens5, Xingyan Kuang6, Nan Zhao6, Dheeraj Malhotra7, Jacob J. Michaelson7,w, Vladimir Vacic8, Michael A. Calderwood2,3, Frederick P. Roth2,3,4, Jan Tavernier5, Steve Horvath9, Kourosh Salehi-Ashtiani2,3,w, Dmitry Korkin6, Jonathan Sebat7, David E. Hill2,3, Tong Hao2,3, Marc Vidal2,3 & Lilia M. Iakoucheva1 Increased risk for autism spectrum disorders (ASD) is attributed to hundreds of genetic loci. The convergence of ASD variants have been investigated using various approaches, including protein interactions extracted from the published literature. However, these datasets are frequently incomplete, carry biases and are limited to interactions of a single splicing isoform, which may not be expressed in the disease-relevant tissue. Here we introduce a new interactome mapping approach by experimentally identifying interactions between brain-expressed alternatively spliced variants of ASD risk factors. The Autism Spliceform Interaction Network reveals that almost half of the detected interactions and about 30% of the newly identified interacting partners represent contribution from splicing variants, emphasizing the importance of isoform networks. Isoform interactions greatly contribute to establishing direct physical connections between proteins from the de novo autism CNVs. Our findings demonstrate the critical role of spliceform networks for translating genetic knowledge into a better understanding of human diseases. -
Supplementary Information Integrative Analyses of Splicing in the Aging Brain: Role in Susceptibility to Alzheimer’S Disease
Supplementary Information Integrative analyses of splicing in the aging brain: role in susceptibility to Alzheimer’s Disease Contents 1. Supplementary Notes 1.1. Religious Orders Study and Memory and Aging Project 1.2. Mount Sinai Brain Bank Alzheimer’s Disease 1.3. CommonMind Consortium 1.4. Data Availability 2. Supplementary Tables 3. Supplementary Figures Note: Supplementary Tables are provided as separate Excel files. 1. Supplementary Notes 1.1. Religious Orders Study and Memory and Aging Project Gene expression data1. Gene expression data were generated using RNA- sequencing from Dorsolateral Prefrontal Cortex (DLPFC) of 540 individuals, at an average sequence depth of 90M reads. Detailed description of data generation and processing was previously described2 (Mostafavi, Gaiteri et al., under review). Samples were submitted to the Broad Institute’s Genomics Platform for transcriptome analysis following the dUTP protocol with Poly(A) selection developed by Levin and colleagues3. All samples were chosen to pass two initial quality filters: RNA integrity (RIN) score >5 and quantity threshold of 5 ug (and were selected from a larger set of 724 samples). Sequencing was performed on the Illumina HiSeq with 101bp paired-end reads and achieved coverage of 150M reads of the first 12 samples. These 12 samples will serve as a deep coverage reference and included 2 males and 2 females of nonimpaired, mild cognitive impaired, and Alzheimer's cases. The remaining samples were sequenced with target coverage of 50M reads; the mean coverage for the samples passing QC is 95 million reads (median 90 million reads). The libraries were constructed and pooled according to the RIN scores such that similar RIN scores would be pooled together. -
Looking at Earth: an Astronaut's Journey Induction Ceremony 2017
american academy of arts & sciences winter 2018 www.amacad.org Bulletin vol. lxxi, no. 2 Induction Ceremony 2017 Class Speakers: Jane Mayer, Ursula Burns, James P. Allison, Heather K. Gerken, and Gerald Chan Annual David M. Rubenstein Lecture Looking at Earth: An Astronaut’s Journey David M. Rubenstein and Kathryn D. Sullivan ALSO: How Are Humans Different from Other Great Apes?–Ajit Varki, Pascal Gagneux, and Fred H. Gage Advancing Higher Education in America–Monica Lozano, Robert J. Birgeneau, Bob Jacobsen, and Michael S. McPherson Redistricting and Representation–Patti B. Saris, Gary King, Jamal Greene, and Moon Duchin noteworthy Select Prizes and Andrea Bertozzi (University of James R. Downing (St. Jude Chil- Barbara Grosz (Harvard Univer- California, Los Angeles) was se- dren’s Research Hospital) was sity) is the recipient of the Life- Awards to Members lected as a 2017 Simons Investi- awarded the 2017 E. Donnall time Achievement Award of the gator by the Simons Foundation. Thomas Lecture and Prize by the Association for Computational American Society of Hematology. Linguistics. Nobel Prize in Chemistry, Clara D. Bloomfield (Ohio State 2017 University) is the recipient of the Carol Dweck (Stanford Univer- Christopher Hacon (University 2017 Robert A. Kyle Award for sity) was awarded the inaugural of Utah) was awarded the Break- Joachim Frank (Columbia Univer- Outstanding Clinician-Scientist, Yidan Prize. through Prize in Mathematics. sity) presented by the Mayo Clinic Di- vision of Hematology. Felton Earls (Harvard Univer- Naomi Halas (Rice University) sity) is the recipient of the 2018 was awarded the 2018 Julius Ed- Nobel Prize in Economic Emmanuel J. -
Mitosis Vs. Meiosis
Mitosis vs. Meiosis In order for organisms to continue growing and/or replace cells that are dead or beyond repair, cells must replicate, or make identical copies of themselves. In order to do this and maintain the proper number of chromosomes, the cells of eukaryotes must undergo mitosis to divide up their DNA. The dividing of the DNA ensures that both the “old” cell (parent cell) and the “new” cells (daughter cells) have the same genetic makeup and both will be diploid, or containing the same number of chromosomes as the parent cell. For reproduction of an organism to occur, the original parent cell will undergo Meiosis to create 4 new daughter cells with a slightly different genetic makeup in order to ensure genetic diversity when fertilization occurs. The four daughter cells will be haploid, or containing half the number of chromosomes as the parent cell. The difference between the two processes is that mitosis occurs in non-reproductive cells, or somatic cells, and meiosis occurs in the cells that participate in sexual reproduction, or germ cells. The Somatic Cell Cycle (Mitosis) The somatic cell cycle consists of 3 phases: interphase, m phase, and cytokinesis. 1. Interphase: Interphase is considered the non-dividing phase of the cell cycle. It is not a part of the actual process of mitosis, but it readies the cell for mitosis. It is made up of 3 sub-phases: • G1 Phase: In G1, the cell is growing. In most organisms, the majority of the cell’s life span is spent in G1. • S Phase: In each human somatic cell, there are 23 pairs of chromosomes; one chromosome comes from the mother and one comes from the father. -
The Role of F-Box Proteins During Viral Infection
Int. J. Mol. Sci. 2013, 14, 4030-4049; doi:10.3390/ijms14024030 OPEN ACCESS International Journal of Molecular Sciences ISSN 1422-0067 www.mdpi.com/journal/ijms Review The Role of F-Box Proteins during Viral Infection Régis Lopes Correa 1, Fernanda Prieto Bruckner 2, Renan de Souza Cascardo 1,2 and Poliane Alfenas-Zerbini 2,* 1 Department of Genetics, Federal University of Rio de Janeiro, Rio de Janeiro, RJ 21944-970, Brazil; E-Mails: [email protected] (R.L.C.); [email protected] (R.S.C.) 2 Department of Microbiology/BIOAGRO, Federal University of Viçosa, Viçosa, MG 36570-000, Brazil; E-Mail: [email protected] * Author to whom correspondence should be addressed; E-Mail: [email protected]; Tel.: +55-31-3899-2955; Fax: +55-31-3899-2864. Received: 23 October 2012; in revised form: 14 December 2012 / Accepted: 17 January 2013 / Published: 18 February 2013 Abstract: The F-box domain is a protein structural motif of about 50 amino acids that mediates protein–protein interactions. The F-box protein is one of the four components of the SCF (SKp1, Cullin, F-box protein) complex, which mediates ubiquitination of proteins targeted for degradation by the proteasome, playing an essential role in many cellular processes. Several discoveries have been made on the use of the ubiquitin–proteasome system by viruses of several families to complete their infection cycle. On the other hand, F-box proteins can be used in the defense response by the host. This review describes the role of F-box proteins and the use of the ubiquitin–proteasome system in virus–host interactions. -
Polo-Like Kinase 1: Target and Regulator of Anaphase-Promoting Complex/Cyclosome–Dependent Proteolysis Frank Eckerdt1 and Klaus Strebhardt2
Review Polo-Like Kinase 1: Target and Regulator of Anaphase-Promoting Complex/Cyclosome–Dependent Proteolysis Frank Eckerdt1 and Klaus Strebhardt2 1Department of Pharmacology, University of Colorado School of Medicine, Denver, Colorado and 2Department of Gynecology and Obstetrics, Medical School, J.W. Goethe-University, Frankfurt, Germany Abstract to the regulation of the APC/C, an E3 ubiquitin ligase that is Polo-like kinase 1 (Plk1) is a key regulator of progression responsible for the timely destruction of various mitotic proteins, through mitosis. Although Plk1 seems to be dispensable for thereby regulating chromosome segregation, exit from mitosis, entry into mitosis, its role in spindle formation and exit from and a stable subsequent G1 phase (3).The APC/C is first activated by the ancillary protein Cdc20, targeting proteins containing a mitosis is crucial. Recent evidence suggests that a major role Cdc20 of Plk1 in exit from mitosis is the regulation of inhibitors of destruction box (D box), like securin.Once APC/C has the anaphase-promoting complex/cyclosome (APC/C), such as initiated mitotic exit, Cdc20 itself is degraded and is replaced by Cdh1, allowing the degradation of a wider spectrum of substrates. the early mitotic inhibitor 1 (Emi1) and spindle checkpoint Cdh1 proteins. Thus, Plk1 and the APC/C control mitotic regulators The APC/C complex targets not only D box–containing proteins but also proteins exhibiting a KEN box and/or an A box by both phosphorylation and targeted ubiquitylation to Cdh1 ensure the fidelity of chromosome separation at the meta- (e.g., cyclin B1 and Aurora A). Plk1 itself is an APC/C target. -
Title: Therapeutic Potential of HSP90 Inhibition for Neurofibromatosis Type 2
Author Manuscript Published OnlineFirst on May 28, 2013; DOI: 10.1158/1078-0432.CCR-12-3167 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. Title: Therapeutic Potential of HSP90 Inhibition for Neurofibromatosis type 2 Karo Tanaka1, Ascia Eskin3, Fabrice Chareyre1, Walter J. Jessen4, Jan Manent5, Michiko Niwa-Kawakita6, Ruihong Chen7, Cory H. White2, Jeremie Vitte1, Zahara M. Jaffer1, Stanley F. Nelson3, Allan E. Rubenstein8, Marco Giovannini1,9§. Authors’ affiliations: House Research Institute, 1Center for Neural Tumor Research and 2Section on Genetics of Hereditary Ear Disorders, Los Angeles, CA; 3Department of Human Genetics, University of California, Los Angeles, CA; 4Informatics, Covance Inc., Princeton, NJ; 5Peter MacCallum Cancer Institute, Melbourne, Australia; 6Inserm U944, CNRS U7212, Université Paris, Institut Universitaire d'Hématologie, Paris, France; 7NexGenix Pharmaceuticals, Burlingame, CA; and 8New York University Langone Medical Center, New York, NY; and Department of Cell and Neurobiology, University of Southern California, Keck School of Medicine, Los Angeles, CA Running title: HSP90 Inhibition for NF2 Keywords: NF2, HSP90 inhibitors, Transcriptome Financial support: This work was supported by a Drug Discovery Initiative Award, Children’s Tumor Foundation, to M.G., and by the House Research Institute. Corresponding author: Marco Giovannini, House Research Institute, Center for Neural Tumor Research, 2100 West 3rd street, Los Angeles, CA90057. Phone: +1-213-989-6708; Fax: +1-213-989-6778; E-mail: [email protected] 1 Downloaded from clincancerres.aacrjournals.org on September 30, 2021. © 2013 American Association for Cancer Research. Author Manuscript Published OnlineFirst on May 28, 2013; DOI: 10.1158/1078-0432.CCR-12-3167 Author manuscripts have been peer reviewed and accepted for publication but have not yet been edited. -
Download the Annual Review PDF 2016-17
Annual Review 2016/17 Pushing at the frontiers of Knowledge Portrait of Dr Henry Odili Nwume (Brasenose) by Sarah Jane Moon – see The Full Picture, page 17. FOREWORD 2016/17 has been a memorable year for the country and for our University. In the ever-changing and deeply uncertain world around us, the University of Oxford continues to attract the most talented students and the most talented academics from across the globe. They convene here, as they have always done, to learn, to push at the frontiers of knowledge and to improve the world in which we find ourselves. One of the highlights of the past twelve months was that for the second consecutive year we were named the top university in the world by the Times Higher Education Global Rankings. While it is reasonable to be sceptical of the precise placements in these rankings, it is incontrovertible that we are universally acknowledged to be one of the greatest universities in the world. This is a privilege, a responsibility and a challenge. Other highlights include the opening of the world’s largest health big data institute, the Li Ka Shing Centre for Health Information and Discovery, and the launch of OSCAR – the Oxford Suzhou Centre for Advanced Research – a major new research centre in Suzhou near Shanghai. In addition, the Ashmolean’s success in raising £1.35 million to purchase King Alfred’s coins, which included support from over 800 members of the public, was a cause for celebration. The pages that follow detail just some of the extraordinary research being conducted here on perovskite solar cells, indestructible tardigrades and driverless cars. -
The Steady-State Repertoire of Human SCF Ubiquitin Ligase Complexes Does Not Require Ongoing Nedd8 Conjugation*□S
Research Author’s Choice © 2011 by The American Society for Biochemistry and Molecular Biology, Inc. This paper is available on line at http://www.mcponline.org The Steady-State Repertoire of Human SCF Ubiquitin Ligase Complexes Does Not Require Ongoing Nedd8 Conjugation*□S J. Eugene Lee‡, Michael J. Sweredoski§, Robert L. J. Graham§, Natalie J. Kolawa‡, Geoffrey T. Smith§, Sonja Hess§, and Raymond J. Deshaies‡¶ʈ The human genome encodes 69 different F-box proteins jugating enzyme (E2). E2 charged with ubiquitin collaborates (FBPs), each of which can potentially assemble with Skp1- with ubiquitin ligase (E3) to ubiquitylate the target substrate. Cul1-RING to serve as the substrate specificity subunit of Multiple ubiquitin transfers may occur in a successive man- an SCF ubiquitin ligase complex. SCF activity is switched ner, resulting in the processive formation of an ubiquitin chain on by conjugation of the ubiquitin-like protein Nedd8 to (3). The second step is the energy-dependent proteolysis of Cul1. Cycles of Nedd8 conjugation and deconjugation the ubiquitin chain-tagged protein by the 26S proteasome acting in conjunction with the Cul1-sequestering factor complex. Cand1 are thought to control dynamic cycles of SCF as- There are nearly 600 ubiquitin ligases encoded in the hu- sembly and disassembly, which would enable a dynamic equilibrium between the Cul1-RING catalytic core of SCF man genome, and up to 241 (over 40%) are potentially drawn 1 and the cellular repertoire of FBPs. To test this hypothe- from the cullin–ring ligase (CRL) family (K. Hofmann, personal sis, we determined the cellular composition of SCF com- communication). -
Ingredients for Success 18Th HFSP Awardees Meeting
Ingredients for success In 2018, we yet again embarked on a new era in the HFSP by Guntram Bauer Fellowship program. After careful internal discussion and HFSPO Director of Scientific Affairs and Communications preparations, the review committee was presided over by a non- reviewing chair. Peter Koopman from the Institute of Molecular Bioscience of the University of Queensland took center stage as chair of this committee. Peter finished a four year tenure as a member of the fellowship review committee in 2016 and arrived back in Strasbourg after a three month sailing trip in the southern Pacific. Peer review at HFSP is not reading tea leaves but serious and demanding work for all involved. Thanks to Peter Koopman we successfully completed the first fellowship review committee run by a non-reviewing chair. We are still not sure what the magic ingredient was that made this fellowship committee stand out. Whether it was a truly committed international review panel, or the drive and oversight of its non-reviewing chair, or simply because of the HFSP Sauce which arrived in the chair's suitcase in Strasbourg. Probably all three, though be assured that we will get to the bottom of the HFSP Sauce! I don’t think we are boasting about HFSP when we say that our Program always tries to synchronize its procedures with the dynamics at the frontiers of science. This is particularly true for our peer review process. Over many years we have made more than just subtle changes to our procedures in response to feedback from the scientific community. -
Multiple Ser/Thr-Rich Degrons Mediate the Degradation of Ci/Gli by the Cul3-HIB/SPOP E3 Ubiquitin Ligase
Multiple Ser/Thr-rich degrons mediate the degradation of Ci/Gli by the Cul3-HIB/SPOP E3 ubiquitin ligase Qing Zhanga,1,2, Qing Shia,1, Yongbin Chena,1, Tao Yuea, Shuang Lia, Bing Wanga, and Jin Jianga,b,3 Departments of aDevelopmental Biology and bPharmacology, University of Texas Southwestern Medical Center at Dallas, Dallas, TX 75390 Communicated by Gary Struhl, Columbia University College of Physicians and Surgeons, New York, NY, October 19, 2009 (received for review September 8, 2009) The Cul3-based E3 ubiquitin ligases regulate many cellular pro- morphogenetic furrow (MF), where HIB acts together with Cul3 cesses using a large family of BTB domain–containing proteins as to degrade Ci, thereby limiting the duration of Hh signaling (11, their target recognition components, but how they recognize 12, 14). The Cul3-HIB regulatory circuit appears to be con- targets remains unknown. Here we identify and characterize served, because Gli proteins such as Gli2 and Gli3 can be degrons that mediate the degradation of the Hedgehog pathway degraded by HIB when expressed in Drosophila, and the mam- transcription factor cubitus interruptus (Ci)/Gli by Cul3-Hedghog– malian homolog of HIB, SPOP, can functionally replace HIB in induced MATH and BTB domain–containing protein (HIB)/SPOP. Ci degrading Ci (11). uses multiple Ser/Thr (S/T)-rich motifs that bind HIB cooperatively How Cul3-based E3 ligases recognize their substrates is to mediate its degradation. We provide evidence that both HIB and unknown, and the specific degrons in their target proteins Ci form dimers/oligomers and engage in multivalent interactions, remain to be identified for individual BTB proteins that function which underlies the in vivo cooperativity among individual HIB- as target-recognition components.